Learnings from the IDM Symposium 2024:
Manuela Runge
PhD | Infectious disease epidemiology | malaria modeling | Former AMMnet board member, AMMnet Values & Guidance committee co-chair
"Global public health in a chaotic world: The role of modeling & data science"
The Institute for Disease Modelling at the Bill and Melinda Gates foundation organized this year a symposium to host speakers and poster presenters from across the world and to facilitate networking and exchange.
After having planned to attend virtually, I am very grateful that I ended up attending in person, as I could imagine me sleeping through the sessions otherwise due to the time-difference - kudos to all who attended and especially to those who presented virtually at night!
To make make most of the event and my attendance, I briefly reflect here on what I have learned and collated a list of software/tools/methods mentioned across talks at the end of this article.
5 personal learnings from the symposium and beyond
The agenda shows a wide breath including innovations in infectious disease modeling, data-driven decision-making, and public health intervention strategies, discussions on global health challenges like malaria, tuberculosis, HIV, and vaccine-preventable diseases, alongside advancements in computational tools and statistical modeling. View full agenda.
Learning 1: The world is big, but parameter sampling can be bigger...
... modeling is only as good as the data and requires careful calibration. So no surprise that there was a session on this topic, presenting advancements on calibration methods.
In one talk the parameter space to sample was compared to the stars in the observable universe (2 × 1023 stars) and in the following talk to the number of estimated mosquitoes on earth (1.1×10^14). I did not know those two items had been tried to be quantified, or that the estimated number would be as high - thanks to Aurelien Cavelan (Swiss TPH) and Tobias Holden (Northwestern University) for great talks and fun-facts included!
Lack of data to inform parameters and related uncertainty in parameters as well as in model structure are reason for the infamous quote "all models are wrong", however, ensemble modelling had shown that the use of multiple models can increase confidence in the results. This approach had received increasing traction and use during COVID-19. ... and still is being used and improved, as I learned in one of the talks about the Scenario Modeling Hub by Justin Lessler (University of North Carolina).
Learning 2: Advancements in AI and use of LLM need to be closely followed...
... for their utility and power to synthesize large volumes of evidence and information, especially in the field of using AI for supporting policy and decision making. The field is evolving quickly, and I have not been following it so far, nor do I understand the methods as much as I would like (at all?). Several exciting new tools and applications were introduced: For instance, BUMPER builds on AI and LLM to synthesize evidence to answer questions from the user, presented by Katherine Rosenfeld, IDM. The framework allows to learn via query instead of by observation. One tangible example for me, was to ask BUMBER in what years to run the next SIA campaigns.
Learning 3: Side meetings and 'chance' meetings enhance the experience and benefit of attending a Symposia...
...apart from the symposium, I was attending side meetings on malaria modelling, which allowed me to stay connected and foster collaboration in that space. In addition, the conversations about model calibration and model comparison were very insightful, malaria is such a complex disease, questions such as temperature dependence of sporogony in mosquitoes of how a clinical case is defined (and how it is modeled) are not trivial at all. Separately, I was also amazed that I was able to meet two collaborators for other (even non-malaria) projects (one at the airport!). Those situations are great, when additional benefit of the travel is generated - especially given that travel, cost, and opportunity cost of not doing project work, are non-negligible considerations for attending such events.
Learning 4: Dilemma of finding the right timing of vaccinations under real world challenges...
...this is not a new learning per se, immunization programs have worked on this for many decades and immunization schedules have been around for long. However, one talk caught my attention on the measles vaccination - vaccinating too early increases the risk of failure, while too late increases the risk of getting measles first. While there are recommended ages (6 and 9 months), in practice children do not come exactly and only at their birthdays to get the vaccine... very excited to hear about the approach to include vaccination delays in the measles model (work by Elizabeth Goult, Max Planck Institute for Infection Biology preprint). The results also showed that there is a high range of optimal ages, depending on the local epidemiology. Having worked on a related age-/time sensitive intervention, that is perennial malaria chemoprevention we had also found that the best operational timing (i.e. reaching highest coverage) and the best epidemiological timing (i.e. targeting when disease burden is highest) do not necessarily overlap. -> recommended schedules need to be tailored to the local context and local epidemiology and risk of transmission.
Learning 5: Closing Remarks - learn from others, share knowledge and strive for a common understanding..
...or at least that's some of the key words that stick to my mind from the closing remarks, when Philip Welkhoff (Director, Malaria; Director, IDM) invited the participants to answer the question:
Question to the audience: "What surprised you? What have you learned?"
Answers from participants to that question included:
Platform to bring different scientists, topics together to allow collaborations where the "sum is bigger than its individual parts"
领英推荐
Strengths of community and shared understanding (of the complexities and scientific challenges as well as excitement)
Collective thinking and advancements to tackle together big questions, such as on cause of deaths and new tools to address this.
Among several other voices of excitement and gratefulness about the event.
Question to the audience to take home from the symposium:
To provide the symposium attendees with some additional questions to ponder about on the way home or way to the office next day, Welkhoff posed additional more specific questions for the modelling community:
How to support partners, decision-makers and other stakeholders to achieve best possible outcomes over time? What is needed to be successful over the next 5 years?
A word of caution was raised regarding the use of LLM's, as they might skip over some of the important thought processes of unfolding the answer to a question, and revealing what it is that we actually try to answer. Importantly, how do we know when we have found the (correct) answer, to a (wrong?) question?
He fittingly closed the symposium of two days packed with technical talks with "Thanks to numbers for existing".
List of highlighted tools, software, or frameworks:
(mostly in random order, some talks I have attended, while some I only discovered upon re-reading the agenda while writing this post, and one I have contributed to (i.e, MultiMalModPy)
Transmission and related models
AI, LLM and related methods
Statistics, Bayesian, and related methods
Other
Did I miss one of the tools that should be mentioned here? Please let me know!
Working to make vaccines equally accessible around the globe
4 个月Thanks Manuela for the great insights